New Title
Blog No. 2
Zantac Litigation
The Trimble Firm, P.L.L.C., handles pharmaceutical cases, including claims involving the prescription and over-the-counter ranitidine drugs, commonly known by the brand name, Zantac. The United States Food and Drug Administration has requested that manufacturers of Zantac pull it from the market immediately. Ongoing investigation by the FDA has determined the levels of a contaminant in the heartburn medication increases over time and when stored at higher than normal temperatures, posing a risk to public health. The contaminant, N-nitrosodimethylamine or NDMA, is a probable human carcinogen. The FDA has been conducting investigation of NDMA levels in ranitidine since the summer of 2019. The drug has already been pulled from the shelves of retailers CVS Walgreen’s and Walmart.
If you are have a history of taking Zantac or its generic and are concerned as to whether it has caused you physical harm or injury, you are welcome to contact The Trimble Firm, P.L.L.C., to discuss your situation and have questions answered.